Global Next Generation Sequencing (NGS) Product Market

Next Generation Sequencing (NGS) Product Comprehensive Study by Type (NGS Consumables, Presequencing Products & Services, NGS Platforms, Bioinformatics, Others), Application (Oncology, Reproductive Health Diagnostic, In-Vitro fertilization, Cardiovascular, Drug Discovery, Agriculture & Animal Research, Others), End User (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech, Others), Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing, Whole Exome Sequencing) Players and Region - Global Market Outlook to 2030

Next Generation Sequencing (NGS) Product Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Next Generation Sequencing (NGS) Product Market Scope
The drivers boosting market growth are decreasing genome sequencing prices, expanding genome mapping initiatives, and rising healthcare costs. The massively parallel sequencing technology known as "next-generation sequencing" (NGS) provides extremely high throughput, scalability, and speed. Using this approach, the nucleotide sequence of entire genomes or specific DNA or RNA portions can be ascertained. The biological sciences have undergone a revolution owing to NGS, which enables laboratories to carry out a wide range of tasks and examine biological systems at a depth never before imaginable.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledThermo Fisher Scientific Inc (United States), Becton, Dickinson, and Company (United States), Nanopore Technologies (United Kingdom), Oxford Nanopore Technologies plc (United Kingdom), MACROGEN CO., LTD. (South Korea), DNASTAR (United States), Zymo Research (United States), Geneious (New Zealand), Partek Incorporated (United States), Agilent Technologies, Inc (United States), QIAGEN (Germany), Illumina, Inc. (United States), bioMérieux (France), Pacific Biosciences of California, Inc. (United States) and GENEWIZ (United States)
CAGR%


The market for the Next Generation Sequencing (NGS) Product is highly competitive and dominated by few key player. The market has a vendor landscape that is extremely competitive. A number of businesses are also taking part in significant mergers and acquisitions as part of crucial plans to increase their market share globally. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Next Generation Sequencing (NGS) Product market throughout the predicted period.

Thermo Fisher Scientific Inc (United States), Becton, Dickinson, and Company (United States), Nanopore Technologies (United Kingdom), Oxford Nanopore Technologies plc (United Kingdom), MACROGEN CO., LTD. (South Korea), DNASTAR (United States), Zymo Research (United States), Geneious (New Zealand), Partek Incorporated (United States), Agilent Technologies, Inc (United States), QIAGEN (Germany), Illumina, Inc. (United States), bioMérieux (France), Pacific Biosciences of California, Inc. (United States) and GENEWIZ (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are 10x Genomics (United States), Bio-Rad Laboratories, Inc. (United States), F. Hoffman La Roche (Switzerland), PerkinElmer Inc. (United States), Takara Bio Inc. (Japan) and Lucigen (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Next Generation Sequencing (NGS) Product market by Type , by Application (Oncology, Reproductive Health Diagnostic, In-Vitro fertilization, Cardiovascular, Drug Discovery, Agriculture & Animal Research and Others) and Region with country level break-up.

On the basis of geography, the market of Next Generation Sequencing (NGS) Product has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
On April 2021, Resolution Bioscience, a pioneer in the creation and marketing of precision oncology solutions based on next-generation sequencing (NGS), has been acquired by Agilent Technologies, Inc. Agilent's NGS-based cancer detection capabilities are complemented and expanded by Resolution Bioscience, which also offers the business cutting-edge technology to better meet the demands of the rapidly expanding precision medicine market. and On August 2021, The healthcare company GRAIL, which specialises in the life-saving early diagnosis of certain malignancies, has been bought by Illumina, Inc. Illumina will continue to operate GRAIL as a distinct business throughout the ongoing regulatory examination by the European Commission. To expedite patient access to a life-saving multi-cancer early-detection test, Illumina acquires GRAIL
On March 2022, for customers using the Illumina NextSeqTM 1000 and NextSeqTM 2000 sequencing systems and the GeoMx® Digital Spatial Profiler, NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced a seamless, cloud-based workflow that enhances the spatial data analysis experience. This integrated, push-button run planning tool now makes it easier to do geographic analyses of whole transcriptomes and proteome analytes.


Influencing Trend:
The primary trend fuelling the market's expansion is an increase in the use of next-generation sequencing (NGS)

Market Growth Drivers:
Decreasing genome sequencing prices drives the market growth and Expanding genome mapping initiatives boost the market growth

Challenges:
Unfavourable reimbursement policies limits the market growth

Restraints:
The market's expansion is hampered by a dearth of skilled professionals and ethical and regulatory restrictions and Lack of standardization and concern related to standardization restrict the market growth

Opportunities:
Increased in healthcare expenditure creates lucrative growth opportunities for the market and Numerous expansion prospects are created by the use of NGS in molecular diagnostics and precision medicine

Key Target Audience
New Entrants and Investors, Laboratories, Hospitals, Diagnostic Centres, Clinics, Research Institutes, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • NGS Consumables
  • Presequencing Products & Services
  • NGS Platforms
  • Bioinformatics
  • Others
By Application
  • Oncology
  • Reproductive Health Diagnostic
  • In-Vitro fertilization
  • Cardiovascular
  • Drug Discovery
  • Agriculture & Animal Research
  • Others
By End User
  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech
  • Others

By Technology
  • Targeted Sequencing & Resequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Decreasing genome sequencing prices drives the market growth
      • 3.2.2. Expanding genome mapping initiatives boost the market growth
    • 3.3. Market Challenges
      • 3.3.1. Unfavourable reimbursement policies limits the market growth
    • 3.4. Market Trends
      • 3.4.1. The primary trend fuelling the market's expansion is an increase in the use of next-generation sequencing (NGS)
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Next Generation Sequencing (NGS) Product, by Type, Application, End User , Technology and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Next Generation Sequencing (NGS) Product (Value)
      • 5.2.1. Global Next Generation Sequencing (NGS) Product by: Type (Value)
        • 5.2.1.1. NGS Consumables
        • 5.2.1.2. Presequencing Products & Services
        • 5.2.1.3. NGS Platforms
        • 5.2.1.4. Bioinformatics
        • 5.2.1.5. Others
      • 5.2.2. Global Next Generation Sequencing (NGS) Product by: Application (Value)
        • 5.2.2.1. Oncology
        • 5.2.2.2. Reproductive Health Diagnostic
        • 5.2.2.3. In-Vitro fertilization
        • 5.2.2.4. Cardiovascular
        • 5.2.2.5. Drug Discovery
        • 5.2.2.6. Agriculture & Animal Research
        • 5.2.2.7. Others
      • 5.2.3. Global Next Generation Sequencing (NGS) Product Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Next Generation Sequencing (NGS) Product: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific Inc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson, and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nanopore Technologies (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Oxford Nanopore Technologies plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. MACROGEN CO., LTD. (South Korea)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. DNASTAR (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Zymo Research (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Geneious (New Zealand)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Partek Incorporated (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Agilent Technologies, Inc (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. QIAGEN (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Illumina, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. BioMérieux (France)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Pacific Biosciences of California, Inc. (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. GENEWIZ (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Next Generation Sequencing (NGS) Product Sale, by Type, Application, End User , Technology and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Next Generation Sequencing (NGS) Product (Value)
      • 7.2.1. Global Next Generation Sequencing (NGS) Product by: Type (Value)
        • 7.2.1.1. NGS Consumables
        • 7.2.1.2. Presequencing Products & Services
        • 7.2.1.3. NGS Platforms
        • 7.2.1.4. Bioinformatics
        • 7.2.1.5. Others
      • 7.2.2. Global Next Generation Sequencing (NGS) Product by: Application (Value)
        • 7.2.2.1. Oncology
        • 7.2.2.2. Reproductive Health Diagnostic
        • 7.2.2.3. In-Vitro fertilization
        • 7.2.2.4. Cardiovascular
        • 7.2.2.5. Drug Discovery
        • 7.2.2.6. Agriculture & Animal Research
        • 7.2.2.7. Others
      • 7.2.3. Global Next Generation Sequencing (NGS) Product Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Next Generation Sequencing (NGS) Product: by Type(USD Million)
  • Table 2. Next Generation Sequencing (NGS) Product NGS Consumables , by Region USD Million (2018-2023)
  • Table 3. Next Generation Sequencing (NGS) Product Presequencing Products & Services , by Region USD Million (2018-2023)
  • Table 4. Next Generation Sequencing (NGS) Product NGS Platforms , by Region USD Million (2018-2023)
  • Table 5. Next Generation Sequencing (NGS) Product Bioinformatics , by Region USD Million (2018-2023)
  • Table 6. Next Generation Sequencing (NGS) Product Others , by Region USD Million (2018-2023)
  • Table 7. Next Generation Sequencing (NGS) Product: by Application(USD Million)
  • Table 8. Next Generation Sequencing (NGS) Product Oncology , by Region USD Million (2018-2023)
  • Table 9. Next Generation Sequencing (NGS) Product Reproductive Health Diagnostic , by Region USD Million (2018-2023)
  • Table 10. Next Generation Sequencing (NGS) Product In-Vitro fertilization , by Region USD Million (2018-2023)
  • Table 11. Next Generation Sequencing (NGS) Product Cardiovascular , by Region USD Million (2018-2023)
  • Table 12. Next Generation Sequencing (NGS) Product Drug Discovery , by Region USD Million (2018-2023)
  • Table 13. Next Generation Sequencing (NGS) Product Agriculture & Animal Research , by Region USD Million (2018-2023)
  • Table 14. Next Generation Sequencing (NGS) Product Others , by Region USD Million (2018-2023)
  • Table 15. South America Next Generation Sequencing (NGS) Product, by Country USD Million (2018-2023)
  • Table 16. South America Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 17. South America Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 18. South America Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 19. South America Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 20. Brazil Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 21. Brazil Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 22. Brazil Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 23. Brazil Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 24. Argentina Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 25. Argentina Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 26. Argentina Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 27. Argentina Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 28. Rest of South America Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 29. Rest of South America Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 30. Rest of South America Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 31. Rest of South America Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 32. Asia Pacific Next Generation Sequencing (NGS) Product, by Country USD Million (2018-2023)
  • Table 33. Asia Pacific Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 34. Asia Pacific Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 35. Asia Pacific Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 36. Asia Pacific Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 37. China Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 38. China Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 39. China Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 40. China Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 41. Japan Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 42. Japan Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 43. Japan Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 44. Japan Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 45. India Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 46. India Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 47. India Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 48. India Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 49. South Korea Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 50. South Korea Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 51. South Korea Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 52. South Korea Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 53. Taiwan Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 54. Taiwan Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 55. Taiwan Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 56. Taiwan Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 57. Australia Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 58. Australia Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 59. Australia Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 60. Australia Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 65. Europe Next Generation Sequencing (NGS) Product, by Country USD Million (2018-2023)
  • Table 66. Europe Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 67. Europe Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 68. Europe Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 69. Europe Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 70. Germany Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 71. Germany Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 72. Germany Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 73. Germany Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 74. France Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 75. France Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 76. France Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 77. France Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 78. Italy Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 79. Italy Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 80. Italy Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 81. Italy Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 82. United Kingdom Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 83. United Kingdom Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 84. United Kingdom Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 85. United Kingdom Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 86. Netherlands Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 87. Netherlands Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 88. Netherlands Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 89. Netherlands Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 90. Rest of Europe Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 91. Rest of Europe Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 92. Rest of Europe Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 93. Rest of Europe Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 94. MEA Next Generation Sequencing (NGS) Product, by Country USD Million (2018-2023)
  • Table 95. MEA Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 96. MEA Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 97. MEA Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 98. MEA Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 99. Middle East Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 100. Middle East Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 101. Middle East Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 102. Middle East Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 103. Africa Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 104. Africa Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 105. Africa Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 106. Africa Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 107. North America Next Generation Sequencing (NGS) Product, by Country USD Million (2018-2023)
  • Table 108. North America Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 109. North America Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 110. North America Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 111. North America Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 112. United States Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 113. United States Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 114. United States Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 115. United States Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 116. Canada Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 117. Canada Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 118. Canada Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 119. Canada Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 120. Mexico Next Generation Sequencing (NGS) Product, by Type USD Million (2018-2023)
  • Table 121. Mexico Next Generation Sequencing (NGS) Product, by Application USD Million (2018-2023)
  • Table 122. Mexico Next Generation Sequencing (NGS) Product, by End User USD Million (2018-2023)
  • Table 123. Mexico Next Generation Sequencing (NGS) Product, by Technology USD Million (2018-2023)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Next Generation Sequencing (NGS) Product: by Type(USD Million)
  • Table 140. Next Generation Sequencing (NGS) Product NGS Consumables , by Region USD Million (2025-2030)
  • Table 141. Next Generation Sequencing (NGS) Product Presequencing Products & Services , by Region USD Million (2025-2030)
  • Table 142. Next Generation Sequencing (NGS) Product NGS Platforms , by Region USD Million (2025-2030)
  • Table 143. Next Generation Sequencing (NGS) Product Bioinformatics , by Region USD Million (2025-2030)
  • Table 144. Next Generation Sequencing (NGS) Product Others , by Region USD Million (2025-2030)
  • Table 145. Next Generation Sequencing (NGS) Product: by Application(USD Million)
  • Table 146. Next Generation Sequencing (NGS) Product Oncology , by Region USD Million (2025-2030)
  • Table 147. Next Generation Sequencing (NGS) Product Reproductive Health Diagnostic , by Region USD Million (2025-2030)
  • Table 148. Next Generation Sequencing (NGS) Product In-Vitro fertilization , by Region USD Million (2025-2030)
  • Table 149. Next Generation Sequencing (NGS) Product Cardiovascular , by Region USD Million (2025-2030)
  • Table 150. Next Generation Sequencing (NGS) Product Drug Discovery , by Region USD Million (2025-2030)
  • Table 151. Next Generation Sequencing (NGS) Product Agriculture & Animal Research , by Region USD Million (2025-2030)
  • Table 152. Next Generation Sequencing (NGS) Product Others , by Region USD Million (2025-2030)
  • Table 153. South America Next Generation Sequencing (NGS) Product, by Country USD Million (2025-2030)
  • Table 154. South America Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 155. South America Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 156. South America Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 157. South America Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 158. Brazil Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 159. Brazil Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 160. Brazil Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 161. Brazil Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 162. Argentina Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 163. Argentina Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 164. Argentina Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 165. Argentina Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 166. Rest of South America Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 167. Rest of South America Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 168. Rest of South America Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 169. Rest of South America Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 170. Asia Pacific Next Generation Sequencing (NGS) Product, by Country USD Million (2025-2030)
  • Table 171. Asia Pacific Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 172. Asia Pacific Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 173. Asia Pacific Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 174. Asia Pacific Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 175. China Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 176. China Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 177. China Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 178. China Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 179. Japan Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 180. Japan Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 181. Japan Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 182. Japan Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 183. India Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 184. India Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 185. India Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 186. India Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 187. South Korea Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 188. South Korea Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 189. South Korea Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 190. South Korea Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 191. Taiwan Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 192. Taiwan Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 193. Taiwan Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 194. Taiwan Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 195. Australia Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 196. Australia Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 197. Australia Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 198. Australia Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 199. Rest of Asia-Pacific Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 200. Rest of Asia-Pacific Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 201. Rest of Asia-Pacific Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 202. Rest of Asia-Pacific Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 203. Europe Next Generation Sequencing (NGS) Product, by Country USD Million (2025-2030)
  • Table 204. Europe Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 205. Europe Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 206. Europe Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 207. Europe Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 208. Germany Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 209. Germany Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 210. Germany Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 211. Germany Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 212. France Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 213. France Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 214. France Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 215. France Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 216. Italy Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 217. Italy Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 218. Italy Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 219. Italy Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 220. United Kingdom Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 221. United Kingdom Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 222. United Kingdom Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 223. United Kingdom Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 224. Netherlands Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 225. Netherlands Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 226. Netherlands Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 227. Netherlands Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 228. Rest of Europe Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 229. Rest of Europe Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 230. Rest of Europe Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 231. Rest of Europe Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 232. MEA Next Generation Sequencing (NGS) Product, by Country USD Million (2025-2030)
  • Table 233. MEA Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 234. MEA Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 235. MEA Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 236. MEA Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 237. Middle East Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 238. Middle East Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 239. Middle East Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 240. Middle East Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 241. Africa Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 242. Africa Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 243. Africa Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 244. Africa Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 245. North America Next Generation Sequencing (NGS) Product, by Country USD Million (2025-2030)
  • Table 246. North America Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 247. North America Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 248. North America Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 249. North America Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 250. United States Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 251. United States Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 252. United States Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 253. United States Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 254. Canada Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 255. Canada Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 256. Canada Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 257. Canada Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 258. Mexico Next Generation Sequencing (NGS) Product, by Type USD Million (2025-2030)
  • Table 259. Mexico Next Generation Sequencing (NGS) Product, by Application USD Million (2025-2030)
  • Table 260. Mexico Next Generation Sequencing (NGS) Product, by End User USD Million (2025-2030)
  • Table 261. Mexico Next Generation Sequencing (NGS) Product, by Technology USD Million (2025-2030)
  • Table 262. Research Programs/Design for This Report
  • Table 263. Key Data Information from Secondary Sources
  • Table 264. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Next Generation Sequencing (NGS) Product: by Type USD Million (2018-2023)
  • Figure 5. Global Next Generation Sequencing (NGS) Product: by Application USD Million (2018-2023)
  • Figure 6. South America Next Generation Sequencing (NGS) Product Share (%), by Country
  • Figure 7. Asia Pacific Next Generation Sequencing (NGS) Product Share (%), by Country
  • Figure 8. Europe Next Generation Sequencing (NGS) Product Share (%), by Country
  • Figure 9. MEA Next Generation Sequencing (NGS) Product Share (%), by Country
  • Figure 10. North America Next Generation Sequencing (NGS) Product Share (%), by Country
  • Figure 11. Global Next Generation Sequencing (NGS) Product share by Players 2023 (%)
  • Figure 12. Global Next Generation Sequencing (NGS) Product share by Players (Top 3) 2023(%)
  • Figure 13. Global Next Generation Sequencing (NGS) Product share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Thermo Fisher Scientific Inc (United States) Revenue, Net Income and Gross profit
  • Figure 16. Thermo Fisher Scientific Inc (United States) Revenue: by Geography 2023
  • Figure 17. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. Becton, Dickinson, and Company (United States) Revenue: by Geography 2023
  • Figure 19. Nanopore Technologies (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. Nanopore Technologies (United Kingdom) Revenue: by Geography 2023
  • Figure 21. Oxford Nanopore Technologies plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Oxford Nanopore Technologies plc (United Kingdom) Revenue: by Geography 2023
  • Figure 23. MACROGEN CO., LTD. (South Korea) Revenue, Net Income and Gross profit
  • Figure 24. MACROGEN CO., LTD. (South Korea) Revenue: by Geography 2023
  • Figure 25. DNASTAR (United States) Revenue, Net Income and Gross profit
  • Figure 26. DNASTAR (United States) Revenue: by Geography 2023
  • Figure 27. Zymo Research (United States) Revenue, Net Income and Gross profit
  • Figure 28. Zymo Research (United States) Revenue: by Geography 2023
  • Figure 29. Geneious (New Zealand) Revenue, Net Income and Gross profit
  • Figure 30. Geneious (New Zealand) Revenue: by Geography 2023
  • Figure 31. Partek Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 32. Partek Incorporated (United States) Revenue: by Geography 2023
  • Figure 33. Agilent Technologies, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 34. Agilent Technologies, Inc (United States) Revenue: by Geography 2023
  • Figure 35. QIAGEN (Germany) Revenue, Net Income and Gross profit
  • Figure 36. QIAGEN (Germany) Revenue: by Geography 2023
  • Figure 37. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Illumina, Inc. (United States) Revenue: by Geography 2023
  • Figure 39. BioMérieux (France) Revenue, Net Income and Gross profit
  • Figure 40. BioMérieux (France) Revenue: by Geography 2023
  • Figure 41. Pacific Biosciences of California, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Pacific Biosciences of California, Inc. (United States) Revenue: by Geography 2023
  • Figure 43. GENEWIZ (United States) Revenue, Net Income and Gross profit
  • Figure 44. GENEWIZ (United States) Revenue: by Geography 2023
  • Figure 45. Global Next Generation Sequencing (NGS) Product: by Type USD Million (2025-2030)
  • Figure 46. Global Next Generation Sequencing (NGS) Product: by Application USD Million (2025-2030)
  • Figure 47. South America Next Generation Sequencing (NGS) Product Share (%), by Country
  • Figure 48. Asia Pacific Next Generation Sequencing (NGS) Product Share (%), by Country
  • Figure 49. Europe Next Generation Sequencing (NGS) Product Share (%), by Country
  • Figure 50. MEA Next Generation Sequencing (NGS) Product Share (%), by Country
  • Figure 51. North America Next Generation Sequencing (NGS) Product Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific Inc (United States)
  • Becton, Dickinson, and Company (United States)
  • Nanopore Technologies (United Kingdom)
  • Oxford Nanopore Technologies plc (United Kingdom)
  • MACROGEN CO., LTD. (South Korea)
  • DNASTAR (United States)
  • Zymo Research (United States)
  • Geneious (New Zealand)
  • Partek Incorporated (United States)
  • Agilent Technologies, Inc (United States)
  • QIAGEN (Germany)
  • Illumina, Inc. (United States)
  • bioMérieux (France)
  • Pacific Biosciences of California, Inc. (United States)
  • GENEWIZ (United States)
Additional players considered in the study are as follows:
10x Genomics (United States) , Bio-Rad Laboratories, Inc. (United States) , F. Hoffman La Roche (Switzerland) , PerkinElmer Inc. (United States) , Takara Bio Inc. (Japan) , Lucigen (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 210 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Next Generation Sequencing (NGS) Product Market Quantitative research analysis
Global Next Generation Sequencing (NGS) Product Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Next Generation Sequencing (NGS) Product Market are by type [NGS Consumables, Presequencing Products & Services, NGS Platforms, Bioinformatics and Others], by end use application [Oncology, Reproductive Health Diagnostic, In-Vitro fertilization, Cardiovascular, Drug Discovery, Agriculture & Animal Research and Others].
The Next Generation Sequencing (NGS) Product Market is gaining popularity and expected to see strong valuation by 2030.
  • Decreasing genome sequencing prices drives the market growth
  • Expanding genome mapping initiatives boost the market growth

Know More About Global Next Generation Sequencing (NGS) Product Market Report?

Have a Query? Click Here

Other Related Reports

Cardiac Marker Analyzers Comprehensive Study by Application (Hospital, Clinic), Types of Cardiac Markers (Troponin, Creatine kinase (CK), Myoblobin, Lactate dehydrogenase (LDH), C-reactive protein (C...
$ 3600
Clinical Data Management and Statistical Analysis Comprehensive Study by Technology (Cloud Computing, Blockchain, Artificial Intelligence, Machine Learning, Other), Service (Electronic Data Integrati...
$ 3800
Dental Digital Radiography Systems Comprehensive Study by Type (Intraoral X-ray Sensors, Digital Panoramic X-rays, Digital Imaging Software, Cone Beam CT, Others), Application (Hospital, Clinic, Dent...
$ 4000
RNA Medicine Comprehensive Study by Type (RNA Interference, ASO, MiRNA, Nucleic Acid Aptamers, Others), Application (Cancer, Diabetes, Genetic Disorder, Cardiovascular Diseases, Others), End User (A...
$ 3800
Pet Animal Health-Products Comprehensive Study by Type (Drug, Vaccine, Feed, Diagnostics, Others), Distribution Channels (Manufacturers, Suppliers, Medical Stores, Online Retailers, Hypermarket/Super...
$ 3800
Bio Mems Microfluidics Comprehensive Study by Type (Biomedical MEMS, Biotechnological MEMS), Application (Capillary Electrophoresis, Isoelectric Focusing, DNA Analysis, Cell Patterning., Other), Mate...
$ 3800